Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
Saved in:
Main Authors: | Kesheng Lin, Weijie Shen, Nailiang Lin, Sijia Li, Liming Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2025-02-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: | https://medicaljournalssweden.se/actadv/article/view/41250 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01) -
Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01) -
Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01) -
Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01) -
Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01)